[Latest] Global Antibacterial Drugs Market Size/Share Worth USD 67.9 Billion by 2032 at a 5.6% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
25 sept. 2023 17h00 HE
|
Custom Market Insights
Austin, TX, USA, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Antibacterial Drugs Market Size, Trends and Insights By Drug Class...
[Latest] Global Alginate Dressings Market Size/Share Worth USD 1,521.2 Million by 2032 at a 5.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
15 août 2023 02h00 HE
|
Custom Market Insights
Austin, TX, USA, Aug. 15, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Alginate Dressings Market Size, Trends and Insights By Grade (Industrial Grade,...
Derm-Biome Pharmaceuticals’ Multi-Target Topical Drug Produces Positive Results in Preclinical Study in Acne
09 janv. 2023 10h00 HE
|
Derm-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals, Inc, a Vancouver based biopharmaceutical company focused on skin health, is pleased to announce that in a...
ContraFect Data Presentations at the 32nd Annual ECCMID Meeting Highlight the Potential of Engineered Lysin CF-370 to Improve Clinical Outcomes and Suppress Antimicrobial Resistance Compared to Antibiotics Alone
27 avr. 2022 08h00 HE
|
ContraFect Corporation
YONKERS, N.Y., April 27, 2022 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a late clinical-stage biotechnology company focused on the discovery and development of direct lytic agents...
Over 38.5% of Lactoferrin Market Revenue to be contributed by Infant Formula Segment; Demand to Grow By 8% CAGR Through 2032: Fact.MR Report 2022
28 févr. 2022 15h34 HE
|
FACT.MR
ROCKVILLE, Md., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Lactoferrin market revenue was estimated at USD 234.5 Mn in 2021 and is expected to grow at a steady CAGR of 8% from 2022 to 2032. The market is...
Provectus Biopharmaceuticals Announces Publication of Pharmaceutical-Grade Rose Bengal’s Activity Against Gram-Positive Bacteria
10 janv. 2022 06h00 HE
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that preclinical research on a formulation of the Company’s pharmaceutical-grade rose bengal against...
Antimicrobial button LIBU’s efficiency confirmed in deactivating the influenza virus
29 sept. 2021 11h33 HE
|
GRB Technologies
QUEBEC CITY, Sept. 29, 2021 (GLOBE NEWSWIRE) -- Canadian company GRB Technologies today unveiled the results of a study of the LIBU germicidal elevator button conducted by the CHU de...
Distribution of Bona Antibacterial Hard-Surface Floor Deep Cleaner Expands
19 avr. 2021 11h18 HE
|
Bona
Milton Keynes, United Kingdom, April 19, 2021 (GLOBE NEWSWIRE) -- Bona®, a global, sustainably-driven company that supplies products for installing, renovating, maintaining, and restoring premium...
Announcing the New Bona® PowerPlus® Antibacterial Surface Cleaner
09 nov. 2020 09h54 HE
|
Bona
Englewood, CO, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Today, Bona US, a global, sustainably-driven company that supplies products for installing, renovating, maintaining and restoring premium floors, is...
C-Bond Systems’ Manufacturing Facility Receives EPA Registration
30 avr. 2020 08h31 HE
|
C-Bond Systems
HOUSTON, April 30, 2020 (GLOBE NEWSWIRE) -- C-Bond Systems, Inc. (the “Company” or “C-Bond”) (OTC: CBNT), a nanotechnology solutions company, today announced its manufacturing facility has received...